Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Martin

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Oncotargets and Therapy|September 15, 2018
Profile of abemaciclib and its potential in the treatment of breast cancerJames M Martin, Lori J Goldstein
JAMA Network Open|October 13, 2020
In Support of CDK4/6 Inhibitors-A Meta-analysis of Available Randomized DataJames M Martin, Lori J Goldstein
Rhode Island Medical Journal (2013)|October 31, 2015
Genomics in acute myeloid leukemia: from identification to personalizationJames M Martin, Eric S Winer
Chinese Clinical Oncology|December 12, 2018
CD30+ T-cell lymphoproliferative disordersJames M Martin, Hong Wu, Stefan K Barta
BMJ Case Reports|January 7, 2018
Rash and subcutaneous fat necrosis after DEB-TACE with doxorubicinAhmed Gamal Elsayed, James M Martin, Toni Pacioles
Annual Review of Physiology|November 4, 2025
Role of Diverse Smooth Muscle Cell Phenotypic Transitions in Atherosclerosis Development and Late-Stage PathogenesisVlad Serbulea, James M Martin, Gary K Owens
JCO Oncology Practice|October 12, 2021
CDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER+ Metastatic Breast CancerPriyanka M Reddy, James M Martin, Alberto J Montero
Ground Water|March 19, 2013
Controls of wellbore flow regimes on pump effluent compositionJames M Martin-Hayden, Mitchell Plummer, Sanford L Britt
The Oncologist|May 13, 2022
Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world DataJames M Martin, Elizabeth A Handorf, Alberto J Montero, et al.
Antioxidants (Basel, Switzerland)|December 1, 2017
Differential Effects of Superoxide Dismutase Mimetics after Mechanical Overload of Articular CartilageMitchell C Coleman, Marc J Brouillette, Nicholas S Andresen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Oncotargets and Therapy|September 15, 2018
Profile of abemaciclib and its potential in the treatment of breast cancerJames M Martin, Lori J Goldstein
JAMA Network Open|October 13, 2020
In Support of CDK4/6 Inhibitors-A Meta-analysis of Available Randomized DataJames M Martin, Lori J Goldstein
Rhode Island Medical Journal (2013)|October 31, 2015
Genomics in acute myeloid leukemia: from identification to personalizationJames M Martin, Eric S Winer
Chinese Clinical Oncology|December 12, 2018
CD30+ T-cell lymphoproliferative disordersJames M Martin, Hong Wu, Stefan K Barta
BMJ Case Reports|January 7, 2018
Rash and subcutaneous fat necrosis after DEB-TACE with doxorubicinAhmed Gamal Elsayed, James M Martin, Toni Pacioles
Annual Review of Physiology|November 4, 2025
Role of Diverse Smooth Muscle Cell Phenotypic Transitions in Atherosclerosis Development and Late-Stage PathogenesisVlad Serbulea, James M Martin, Gary K Owens
JCO Oncology Practice|October 12, 2021
CDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER+ Metastatic Breast CancerPriyanka M Reddy, James M Martin, Alberto J Montero
Ground Water|March 19, 2013
Controls of wellbore flow regimes on pump effluent compositionJames M Martin-Hayden, Mitchell Plummer, Sanford L Britt
The Oncologist|May 13, 2022
Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world DataJames M Martin, Elizabeth A Handorf, Alberto J Montero, et al.
Antioxidants (Basel, Switzerland)|December 1, 2017
Differential Effects of Superoxide Dismutase Mimetics after Mechanical Overload of Articular CartilageMitchell C Coleman, Marc J Brouillette, Nicholas S Andresen, et al.
Pageof 2